THESE MATERIALS ARE BEING MADE AVAILABLE ON THIS WEBSITE BY WOCKHARDT LIMITED (THE 'COMPANY') SOLELY TO COMPLY WITH THE SECURITIES AND EXCHANGE BOARD OF INDIA (ISSUE OF CAPITAL AND DISCLOSURE REQUIREMENTS) REGULATIONS, 2018, AS AMENDED ('SEBI ICDR REGULATIONS') AND THE COMPANIES ACT, 2013 AND THE RULES MADE THEREUNDER, EACH AS AMENDED ('COMPANIES ACT'). THESE MATERIALS ARE BEING MADE AVAILABLE ON THIS WEBSITE BY WOCKHARDT LIMITED (THE ' COMPANY ') SOLELY TO COMPLY WITH THE SECURITIES AND EXCHANGE BOARD OF INDIA (ISSUE OF CAPITAL AND DISCLOSURE REQUIREMENTS) REGULATIONS, 2018, AS AMENDED (' SEBI ICDR REGULATIONS ') AND THE COMPANIES ACT, 2013 AND THE RULES MADE THEREUNDER, EACH AS AMENDED (' COMPANIES ACT '). Wockhardt is a global pharmaceutical and biotechnology organisation with a chain of advanced super specialty hospitals. It provides affordable, high-quality medicines and innovates in complex and challenging medical technologies. Wockhardt is a public company founded by Dr. Habil Khorakiwala in the 1960s. It produces formulations, biopharmaceuticals, vaccines and APIs, and has subsidiaries and plants in several countries.
